Annals of Family Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Annals of Family Medicine 4:433-436 (2006)
© 2006 Annals of Family Medicine, Inc.
doi: 10.1370/afm.576
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow In Brief
Right arrow TRACK Discussion: Submit a Comment
Right arrow TRACK Discussion: View Comments
Right arrow Alert me when this article is cited
Right arrow Alert me when TRACK Comments are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McFall, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McFall, S. L.

US Men Discussing Prostate-Specific Antigen Tests With a Physician

Stephanie L. McFall, PhD

University of Texas Health Science Center, School of Public Health, San Antonio, Tex

CORRESPONDING AUTHOR: Stephanie L. McFall, PhD Health Science Center, School of Public Health, University of Texas, San Antonio Regional Campus, 7703 Floyd Curl Drive, mc 7976, San Antonio, TX 78229, Stephanie.l.mcfall{at}uth.tmc.edu

PURPOSE Informed decision making is recommended for prostate cancer screening. I wanted to examine demographic and screening-related factors associated with men’s discussion of the advantages and disadvantages of prostate-specific antigen (PSA) tests with their physicians.

METHODS I used data from 2,184 men aged 50 years and older who reported a screening prostate-specific antigen (PSA) test in the 2000 National Health Interview Survey cancer control supplement. The dependent variable was discussion of the advantages and disadvantages of the test before it was conducted.

RESULTS Sixty-three percent of tested men reported a discussion in relation to their most recent PSA test. Discussion was more common for African American men and those with a usual source of care, and when the physician initiated the testing.

CONCLUSIONS Characteristics of the patient-physician relationship were more central to the discussion of risks and benefits than were patient attributes. Future research should examine what role practice setting and the physician-patient relationship play in a discussion of PSA testing and how to facilitate active involvement of patients in decision making.

Key Words: Prostate cancer/screening • prostate-specific antigen • patient-physician communication • decision making • health surveys, informed consent




This article has been cited by other articles:


Home page
 CA Cancer J ClinHome page
R. A. Smith, V. Cokkinides, and O. W. Brawley
Cancer Screening in the United States, 2008: A Review of Current American Cancer Society Guidelines and Cancer Screening Issues
CA Cancer J Clin, May 1, 2008; 58(3): 161 - 179.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
A. G Papatsoris and F. Anagnostopoulos
Men's behaviour towards prostate cancer screening
Postgrad. Med. J., February 1, 2008; 84(988): 57 - 59.
[Full Text] [PDF]

Home page
 Ann Fam MedHome page
K. C. Stange
On TRACK: Challenges and Insights
Ann. Fam. Med, November 1, 2006; 4(6): 561 - 563.
[Full Text] [PDF]

Home page
 Ann Fam MedHome page
K. C. Stange
In This Issue: Capacity for Caring and Generating New Knowledge
Ann. Fam. Med, September 1, 2006; 4(5): 386 - 388.
[Full Text] [PDF]

TRACK Comments:

Read all TRACK Comments

PSA patient information: Be mindful how you use it
David L. Hahn
Annals of Family Medicine, 3 Oct 2006 [Full text]

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Annals of Family Medicine.